May 6, interim report
January – March 2024
Alligator will host a conference call on Monday at 3:00 p.m. CEST/ 9:00 a.m. EST for investors, analysts and media, where CEO Søren Bregenholt and CFO Marie Svensson will present and comment on the Q1 interim report, which will be followed by a Q&A session. The call will be held in English, and can be accessed through Alligator’s channels on YouTube.
LATEST NEWS
Alligator Bioscience Announces Initiation of an Investigator-Initiated Initiation of Phase 1 Clinical Study of Intratumoral Mitazalimab in Locally Advanced Pancreatic Cancer
Study conducted by Moores Cancer Center at University of California San Diego to evaluate safety and efficacy of mitazalimab injected intrat …
Bulletin from the annual general meeting in Alligator Bioscience AB on 7 May 2024
The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedis …
Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update
Mitazalimab Phase 3 preparations underway following positive top-line results from OPTIMIZE-1 Phase 2 study in pancreatic cancer Positive in …